Solamargine is widely studied for its potential anticancer properties. It has shown activity against various cancer cell lines, including liver, lung, and cervical cancers, by inducing apoptosis and inhibiting cell proliferation. Research suggests it may enhance the effectiveness of conventional chemotherapy drugs while reducing their side effects. It is also explored for its antiviral and anti-inflammatory effects, particularly in traditional medicine formulations. Due to its ability to target multiple signaling pathways, solamargine is considered a promising candidate in the development of novel therapeutic agents, especially in integrative oncology. However, most studies are still in preclinical stages, primarily conducted in vitro or in animal models.